Van Gorp T, Cibula D, Lv W, Backes F, et al. ENGOT-en11/GOG-3053/KEYNOTE-B21: A Randomised, Double-Blind, Phase 3 Study of Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy in Patients With Newly Diagnosed, High-Risk Endometrial Cancer. Ann Oncol 2024 Aug 23:S0923-7534(24)03822-5. doi: 10.1016/j.annonc.2024.08.2242.
PMID: 39284383